Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells

Molecular Cancer Therapeutics
Mathias SchmidtVolker Gekeler

Abstract

Multiple roles within mitosis have been assigned to Polo-like kinase 1 (Plk1), making it an attractive candidate for mitotic targeting of cancer cells. We have employed chimeric antisense oligonucleotides to investigate the molecular alterations after targeted interference with Plk1 in RKO human colon adenocarcinoma and PC3 prostate cancer cells. Suppression of Plk1 mRNA resulted in a dramatic increase of the mitotic index followed by the onset of apoptosis. Mitotically arrested cells displayed randomly separated condensed chromosomes and the occurrence of multiple spindle poles with well-formed asters. Induction of apoptosis was strictly dependent on cell cycle progression: Genetically engineered RKO cells with inducible expression of the cyclin-dependent kinase inhibitor p27(Kip1) were completely refractory to Plk1 depletion-induced apoptosis when they were arrested in the G1 phase of the cell cycle. Various mitotic markers, including MPM-2, cdc25c, cyclin B1, or phosphorylated histone H3, were investigated to explore the molecular consequences of Plk1 depletion. Whereas most marker proteins showed similar alterations compared with treatment with paclitaxel, cdc25c was fully phosphorylated solely in paclitaxel-treated cells b...Continue Reading

References

May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·F M DavisP N Rao
Jun 15, 1995·The Biochemical Journal·J Pines
Feb 25, 1997·Experimental Cell Research·M DingD D Vandré
Sep 22, 2000·The Biochemical Journal·S P DaviesP Cohen
Mar 19, 2002·EMBO Reports·Fumiko Toyoshima-MorimotoEisuke Nishida
Jun 6, 2002·Journal of the National Cancer Institute·Colin B Begg, Peter B Bach
Nov 28, 2002·Biological Chemistry·Yu Shi, Matthias Gaestel
Jan 14, 2003·Nature Cell Biology·Mark JackmanJonathon Pines
Feb 26, 2003·The Biochemical Journal·Ricardo M Biondi, Angel R Nebreda
Apr 30, 2003·The Journal of Cell Biology·Claire DitchfieldStephen S Taylor
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
May 10, 2003·The Journal of Biological Chemistry·Hiroyuki NakajimaEisuke Nishida
Jul 11, 2003·Developmental Cell·Martina CasenghiErich A Nigg
Jul 11, 2003·Developmental Cell·Tianhua ZhouRaymond L Erikson
Aug 27, 2003·The Journal of Cell Biology·Rüdiger NeefFrancis A Barr
Feb 19, 2004·British Journal of Cancer·W WeichertS Hauptmann
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yakir MosheAvram Hershko
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Francis A BarrErich A Nigg
Jun 11, 2004·The Journal of Biological Chemistry·Hong ZhangSteven Pelech
Sep 8, 2004·Molecular Cell·Marcel A T M van VugtRené H Medema
Jan 11, 2005·Oncogene·Noriyuki TakaiIsao Miyakawa
Jan 22, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-Shaw, Nihal Ahmad
Mar 16, 2005·Cancer Cell·Kiranmai GumireddyE Premkumar Reddy
Mar 24, 2005·Virchows Archiv : an International Journal of Pathology·Wilko WeichertCarsten Denkert
Apr 20, 2005·Oncogene·Marcel A T M van Vugt, René H Medema
Apr 28, 2005·Current Topics in Medicinal Chemistry·Campbell McInnesPeter M Fischer
Jun 16, 2005·Molecular Cancer Therapeutics·Yan LuoVincent L Giranda

❮ Previous
Next ❯

Citations

Dec 23, 2008·Molecular & Cellular Proteomics : MCP·Rod K NibbeMark R Chance
Aug 2, 2012·Biochemistry Research International·Geun-Hyoung Ha, Eun-Kyoung Yim Breuer
Jun 12, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Meihua SuiWeimin Fan
Aug 3, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mathias Schmidt, Holger Bastians
Apr 12, 2017·FEBS Open Bio·Mark C de GooijerOlaf van Tellingen
Nov 30, 2019·Molecular and Cellular Biochemistry·Aijaz RashidDulal Panda
Feb 3, 2007·Molecular Cancer Therapeutics·Timothy J LansingMui Cheung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.